Phosphate dysregulation via the XPR1–KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer
Daniel P. Bondeson, Brenton R. Paolella, Adhana Asfaw, Michael Rothberg, Thomas A. Skipper, Carly R. Langan, Gabriel Mesa, Alfredo González, Lauren E. Surface, Kentaro Ito, Mariya Kazachkova, William Colgan, Allison Warren, Joshua M. Dempster, John M. Krill-Burger, Maria Ericsson, Andrew Tang, Iris Fung, Emily S. Chambers, Mai Abdusamad, Nancy Dumont, John G. Doench, Federica Piccioni, David E. Root, Jesse S. Boehm, William C. Hahn, Michael Mannstadt, James M. McFarland, Francisca Vázquez, Todd R. Golub
Topics & Concepts
Ovarian cancerVulnerability (computing)CancerPhosphateCancer researchOncologyMedicineInternal medicineBiologyBiochemistryComputer scienceComputer securityGenetic and Kidney Cyst DiseasesRenal and related cancersMechanisms of cancer metastasis